Effectiveness of stereotactic body radiotherapy for portal vein tumor thrombosis in patients with hepatocellular carcinoma and underlying chronic liver disease

Stereotactic‐body radiotherapy (SBRT) is a treatment option for portal vein tumor thrombosis (PVTT) in patients with hepatocellular carcinoma (HCC). Here, we report on our experience of treating PVTT using SBRT in patients with concomitant underlying chronic liver disease.

• Publication year

  2020

• Venue

  Asia-Pacific Journal of Clinical Oncology

• Publication date

  2020-08-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/ajco.13361PMID 32757461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

  2018cited by this paper
• Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014

  2017cited by this paper
• Characteristics and outcomes of chronic liver disease patients with acute deteriorated liver function by severity of underlying liver disease.

  2016cited by this paper
• New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis

  2015cited by this paper
• Current management of hepatocellular carcinoma: an Eastern perspective.

  2015cited by this paper
• 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma

  2015cited by this paper
• Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma.

  2015cited by this paper
• Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012

  2015cited by this paper
• Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein.

  2015cited by this paper
• Three-dimensional conformal radiotherapy for portal vein tumor thrombosis alone in advanced hepatocellular carcinoma

  2014cited by this paper
• Stereotactic body radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis.

  2014cited by this paper
• The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma

  2014cited by this paper
• Effectiveness of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma with Portal Vein and/or Inferior Vena Cava Tumor Thrombosis

  2013cited by this paper
• High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma

  2013cited by this paper
• Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010

  2013cited by this paper
• Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapy

  2013cited by this paper
• Clinical and Epidemiological Aspects of Hepatocellular Carcinoma in Brazil

  2013cited by this paper
• Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.

  2012cited by this paper
• Radiotherapy for hepatocellular carcinoma: Systematic review of radiobiology and modeling projections indicate reconsideration of its use

  2010cited by this paper
• Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

  2010cited by this paper
• The treatment responses in cases of radiation therapy to portal vein thrombosis in advanced hepatocellular carcinoma.

  2009cited by this paper
• Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis

  2008cited by this paper
• Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

  2008cited by this paper
• Epidemiology of hepatocellular carcinoma.

  2005cited by this paper
• Three‐dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma

  2005cited by this paper
• Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum.

  2004cited by this paper
• European Association for the Study of the Liver

  1971cited by this paper

• CT-guided high-dose-rate brachytherapy ablation of HCC patients with portal vein tumor thrombosis

  2025cites this paper
• Advances in transarterial chemoembolization for hepatocellular carcinoma: Integration with systemic therapies and emerging treatment strategies

  2025cites this paper
• Efficacy and safety of image-guided hypofractionated radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective, multicenter study

  2025cites this paper
• Case Report: Abscopal effect in a patient with refractory metastatic hepatocellular carcinoma treated with stereotactic body radiotherapy and PD-1 inhibitor

  2025cites this paper
• Proton Beam Therapy for Untreated Hepatocellular Carcinoma Unsuitable for Transcatheter Arterial Chemoembolization.

  2025cites this paper
• Magnetic resonance imaging-guided radiotherapy for portal vein tumor thrombus in hepatocellular carcinoma: outcomes and prognostic factors

  2025influential citation
• Intensity-Modulated Proton Therapy for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

  2025cites this paper
• Characteristics of HCC Patients with Portal Vein Thrombosis: Albumin and Survival

  2024cites this paper
• Management of Hepatocellular Carcinoma in 2024: The Multidisciplinary Paradigm in an Evolving Treatment Landscape

  2024cites this paper
• Comparative efficacy and safety of multimodality treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: patient-level network meta-analysis

  2024cites this paper
• Comparison of stereotactic body radiotherapy and transcatheter arterial chemoembolization for hepatocellular carcinoma: Systematic review and meta-analysis.

  2024cites this paper
• Combined radiotherapy and immune checkpoint inhibition for the treatment of advanced hepatocellular carcinoma

  2023cites this paper
• Liver transplantation and resection in patients with hepatocellular cancer and portal vein tumor thrombosis: Feasible and effective?

  2023cites this paper
• Are patients with hepatocellular carcinoma and portal vein tumour thrombosis candidates for liver transplantation?

  2023cites this paper
• Is hepatocellular carcinoma complicated with portal vein tumor thrombosis potentially curable by radiotherapy in the form of stereotactic body radiation therapy?

  2022influential citation
• Stereotactic body radiotherapy plus transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma patients with portal vein tumour thrombus: A meta-analysis

  2022influential citation
• Liver transplantation and portal vein tumour thrombus: futile enterprise?

  2022cites this paper
• The Current Role of Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma (HCC)

  2022cites this paper
• An observational study on tumour response of portal vein tumour thrombus in hepatocellular carcinoma.

  2022cites this paper
• Comparison of External Beam Radiation Therapy Modalities for Hepatocellular Carcinoma With Macrovascular Invasion: A Meta-Analysis and Systematic Review

  2022cites this paper
• Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case series

  2021cites this paper
• Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review

  2021cites this paper
• Management of Portal Vein Thrombosis in Liver Cancer

  2021cites this paper
• Combination of yttrium-90 radioembolization with stereotactic body radiation therapy in the treatment of portal vein tumor thrombosis

  2021cites this paper
• MRI-guided radiotherapy for PVTT in HCC patients: evaluation of the efficacy and safety

  2021cites this paper
• Advanced radiotherapy technique in hepatocellular carcinoma with portal vein thrombosis: Feasibility and clinical outcomes

  2021cites this paper
• HIỆU QUẢ VÀ ĐỘ AN TOÀN CỦA XẠ TRỊ LẬP THỂ ĐỊNH VỊ THÂN TRONG ĐIỀU TRỊ UNG THƯ BIỂU MÔ TẾ BÀO GAN CÓ HUYẾT KHỐI TĨNH MẠCH CỬA

  2021cites this paper
• World Journal of Hepatology

  year unknowninfluential citation